VolitionRX Limited (VNRX)
(Delayed Data from AMEX)
$0.72 USD
-0.01 (-0.98%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $0.70 -0.02 (-2.78%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
VolitionRX Limited [VNRX]
Reports for Purchase
Showing records 41 - 60 ( 100 total )
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
2017 1Q Financial Results; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
2017 1Q Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
2016 Financial Results Reported; Nu.Q EU Launch On Track; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
2016 Financial Results Reported; Nu.Q EU Launch On Track; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
CE Mark Designation Received; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
CE Mark Designation Received; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
3Q16 Financial Results; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
3Q16 Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
NuQ Triage Colorectal Cancer Blood Test to Be Launched in Early 2017
Provider: Rodman & Renshaw, Co.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
NuQ Triage Colorectal Cancer Blood Test to Be Launched in Early 2017; Reiterate Buy and Adjust Price Target to $10
Provider: H.C. Wainwright & Co., Inc.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
2Q16 Financial Results; NuQ? Colorectal Cancer Test Launch in 2016 and Revenue in 2017; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
2Q16 Financial Results; NuQ? Colorectal Cancer Test Launch in 2016 and Revenue in 2017; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Publication on the Stability of NuQ? Biomarkers; USPSTF Updates CRC Screening Guidelines; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: VolitionRX Limited
Industry: Medical - Biomedical and Genetics
Publication on the Stability of NuQ? Biomarkers; USPSTF Updates CRC Screening Guidelines; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.